SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Positive Phase 3 DAYBREAK results in wet age-related macular degeneration are driving attention: Zenkuda and tabirafusp-ted met primary endpoints, and Zenkuda showed six-month dosing durability for many patients. Traders are celebrating the sharp rally and possible short squeeze, while others question Kodiaks valuation given it remains precommercial and flag potential dilution and profit-taking risks.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

HBARs sharp breakout above resistance on unusually heavy volume has traders celebrating momentum and speculating about a short squeeze. Many link the move to IBM-related enterprise AI and digital-identity integration, while others say the catalyst is unclear and warn that profit-taking could reverse the rally.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB shares sold off sharply after CEO CJ Desai stepped down to join Meta, with former CEO Dev Ittycheria named interim chief ahead of the investor day. Traders debate whether the abrupt transition creates meaningful uncertainty or is an overreaction, noting that guidance was reaffirmed and Ittycherias return may provide continuity.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius federal defense grant to convert a U.S. battery line for high-energy-density drone cells is driving attention, with traders viewing it as support for domestic manufacturing and future capacity. The initial enthusiasm faded into a sharp pullback, prompting debate over the long lead time and whether the grant will translate into near-term revenue.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Reports that Trump may ease Iran sanctions and release frozen assets in exchange for nuclear progress drove a sharp, volatile SPY rebound, though traders debated whether the headline was credible or represented meaningful progress. Persistent concern over elevated Treasury yields and oil prices remained a counterweight to the rally.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

CLFs selloff is being linked by traders to the proposed Mesabi Metallics steel plant in Iowa, with debate over whether it could threaten Cleveland-Cliffs competitive position or its Minnesota leases. Some traders dismiss the project as uncertain without tax-break approvals, while others remain focused on strong steel prices, upcoming earnings, and a possible POSCO partnership.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

A large, discounted financing following positive VK2735 obesity-maintenance data is driving attention, as traders debate whether the added cash strengthens Vikings position or whether dilution and the timing of the raise have derailed the rally. Some remain bullish on the drugs potential and speculate about a partnership or acquisition, while others point to a long wait for further clinical catalysts and criticize management; no deal is confirmed.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Rising Treasury yields and higher oil amid Iran/Hormuz tensions are pressuring tech stocks and driving volatile moves in QQQ. Traders are divided between expecting further declines as rates stay elevated and buying sharp rebounds, while speculation about Iran negotiations and Trump remarks has added to the whipsaw.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quants reported selection by The Clearing House for interoperability and transaction management in its on-chain money initiative is driving attention, with community discussion also pointing to UK banks tokenized-deposit activity. Traders are bullish on institutional adoption and QNTs limited supply, while skeptics question whether the partnerships create direct token demand and warn that the sharp rally has brought volatile profit-taking.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

Renewed uncertainty over the proposed Hapag-Lloyd acquisition is driving discussion, with traders circulating reports of Israeli government opposition and debating whether a competing offer could emerge. Some see deal risk as a negative, while others argue a failed sale could leave ZIM benefiting from strong freight rates and potential dividends.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CRBU FDA alignment for pivotal Phase 3:  
 
Caribou has reached agreement with FDA on the design of the planned ANTLER-3 Phase 3 trial for vispa-cel.  
 
The planned study is approximately 250 patients...

Jake

Kevin Roger

Moon Tomorrow

Robert Glenn

Moneyman1877

mv2018

Jon Brandon

Eric Booker

StockTwits Web

Caribou Biosciences Inc

 FDA alignment for pivotal Phase 3:  
 
Caribou has reached agreement with FDA on the design of the planned ANTLER-3 Phase 3 trial for vispa-cel.  
 
The planned study is approximately 250 patients...